Related references
Note: Only part of the references are listed.ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Yosra Messai et al.
CANCER RESEARCH (2014)
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer
Yusuke Goto et al.
FEBS LETTERS (2014)
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
S. Masciarelli et al.
ONCOGENE (2014)
RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model
F. L. Byrne et al.
ONCOGENE (2014)
EGF receptor trafficking: consequences for signaling and cancer
Alejandra Tomas et al.
TRENDS IN CELL BIOLOGY (2014)
LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers
Haiyang Yu et al.
NATURE COMMUNICATIONS (2014)
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
Xiaoyan Li et al.
ONCOTARGET (2014)
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma
Juan Liu et al.
ONCOTARGET (2014)
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Tomer Cooks et al.
CANCER CELL (2013)
TNRC9 Downregulates BRCA1 Expression and Promotes Breast Cancer Aggressiveness
Jingxuan Shan et al.
CANCER RESEARCH (2013)
Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers
Jerome Lacombe et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
First identification of small-molecule inhibitors of Pontin by combining virtual screening and enzymatic assay
Judith Elkaim et al.
BIOCHEMICAL JOURNAL (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
Javier E. Girardini et al.
CANCER CELL (2011)
A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis
Kenzui Taniue et al.
EMBO REPORTS (2011)
Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis
P. Bist et al.
ONCOGENE (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
Perry Stambolsky et al.
CANCER CELL (2010)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Wenwei Hu et al.
MOLECULAR CELL (2010)
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein
Zhaohui Feng et al.
TRENDS IN CELL BIOLOGY (2010)
Regulation of gap-junction protein connexin 43 by β-adrenergic receptor stimulation in rat cardiomyocytes
Yi Xia et al.
ACTA PHARMACOLOGICA SINICA (2009)
Gap Junctions and Cancer: New Functions for an Old Story
Laurent Cronier et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53
Sue Haupt et al.
CANCER RESEARCH (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein
Ya-Wen Chen et al.
CANCER RESEARCH (2008)
Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly
Andrew S. Venteicher et al.
CELL (2008)
Human Rvbl/Tip49 is required for the histone acetyltransferase activity of Tip60/NuA4 and for the Downregulation of phosphorylation on H2AX after DNA damage
Sudhakar Jha et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Chaperone-dependent stabilization and degradation of p53 mutants
P. Muller et al.
ONCOGENE (2008)
The AAA plus superfamilly - a myriad of motions
Paul A. Tucker et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex
JY Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc
MA Wood et al.
MOLECULAR CELL (2000)
Share Paper
